PALM c.34_35inv ;(p.Q12W)

Variant ID: 19-726166-CA-TG

NM_002579.2(PALM):c.34_35inv;(p.Q12W)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Pharmacological agents in development for diabetic macular edema.

International Journal Of Retina And Vitreous
Sadiq, Mohammad Ali MA; Halim, Muhammad Sohail MS; Hassan, Muhammad M; Onghanseng, Neil N; Karaca, Irmak I; Agarwal, Aniruddha A; Afridi, Rubbia R; Sepah, Yasir J YJ; Do, Diana V DV; Nguyen, Quan Dong QD
Publication Date: 2020

Variant appearance in text: PALM: q12w
PubMed Link: 32670612
Variant Present in the following documents:
  • Main text
View BVdb publication page



Beyond Antibodies: The DARPinĀ® Drug Platform.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals And Gene Therapy
Stumpp, Michael T MT; Dawson, Keith M KM; Binz, H Kaspar HK
Publication Date: 2020-08

Variant appearance in text: PALM: q12w
PubMed Link: 32583318
Variant Present in the following documents:
  • Main text
  • 40259_2020_Article_429.pdf
View BVdb publication page



Abicipar pegol: the non-monoclonal antibody anti-VEGF.

Eye (London, England)
Sharma, Ashish A; Kumar, Nilesh N; Kuppermann, Baruch D BD; Bandello, Francesco F
Publication Date: 2020-05

Variant appearance in text: PALM: q12w
PubMed Link: 31570812
Variant Present in the following documents:
  • Main text
View BVdb publication page